Markets · Asia · Tokyo

4502.T Takeda Pharmaceutical Company Limited

¥5,816 +0.87%

Asia · Pharmaceuticals

Log

Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.

+0.87%

YTD

+34.10%

P/E

—

P/B

—

ROE

—

Div yield

—

Beta

0.1

Market cap

—

RSI (14)

Next earnings

—

Previous session

close of Oct 8, 2026 · EOD, no live order book

Open

¥5,859

¥5,816

VWAP (n/a)

—

Day high

¥5,870

Day low

¥5,760

Volume

4.5M

VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.

Latest headlines

eClinical Solutions Turns Clinical Data Intelligence Into Action at ENGAGE 2026

Yahoo Finance · Oct 8

Asian Equities Traded in the US as American Depositary Receipts Tumble in Wednesday Trading

Yahoo Finance · Oct 7

Biopharma's Leapfrog Moment: The Launch of the Digital CMC Consortium

Yahoo Finance · Oct 6

Takeda (TSE:4502) Stock Looks Below Fair Value Even After A 120% Run

Yahoo Finance · Oct 1

Corus International Receives $6.4 Million Grant From Takeda to Reduce Climate-Related Health Risks in Nepal

Yahoo Finance · Oct 1

Will Zasocitinib’s Phase 3 Outperformance Reshape Takeda Pharmaceutical's (TSE:4502) Immunology-Driven Pipeline Narrative

Yahoo Finance · Oct 1

Headlines via Yahoo Finance · links open the source · not an endorsement.

Research & reports

TradingView ↗

Charts & analysis

Yahoo Finance ↗

Quote & news

External resources — availability and opinions are theirs, not ours.

This is reference data for your own analysis — not a recommendation to buy or sell 4502.T. Try it in the Lab to size a position and see the risk.